Zeping Wang - Search Results

Year	Number of Results
2002	3
2005	2
2007	3
2008	2
2009	2
2010	2
2011	1
2012	1
2013	2
2014	3
2015	1
2016	1
2017	2
2018	2
2019	7
2020	7
2021	14
2022	14
2023	25
2024	7

1

Polydatin protects against atherosclerosis by activating autophagy and inhibiting pyroptosis mediated by the NLRP3 inflammasome.

Zhang X, Wang Z, Li X, Chen J, Yu Z, Li X, Sun C, Hu L, Wu M, Liu L. Zhang X, et al. Among authors: wang z. J Ethnopharmacol. 2023 Jun 12;309:116304. doi: 10.1016/j.jep.2023.116304. Epub 2023 Mar 2. J Ethnopharmacol. 2023. PMID: 36870461

2

Farnesoid X receptor: From Structure to Function and Its Pharmacology in Liver Fibrosis.

Ding C, Wang Z, Dou X, Yang Q, Ning Y, Kao S, Sang X, Hao M, Wang K, Peng M, Zhang S, Han X, Cao G. Ding C, et al. Among authors: wang z. Aging Dis. 2023 Oct 9. doi: 10.14336/AD.2023.0830. Online ahead of print. Aging Dis. 2023. PMID: 37815898 Review.

3

Effect of Different Types and Dosages of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Lipoprotein(a) Levels: A Network Meta-analysis.

Yu Z, Hu L, Sun C, Wang Z, Zhang X, Wu M, Liu L. Yu Z, et al. Among authors: wang z. J Cardiovasc Pharmacol. 2023 Jun 1;81(6):445-453. doi: 10.1097/FJC.0000000000001419. J Cardiovasc Pharmacol. 2023. PMID: 36972559

4

Supramolecular-Interactions-Modulated Photoluminescence in Indium Bromide-Based Isomers.

Lin HW, Lin YP, Huang DD, Chen ZH, Peng YC, Wang ZP, Du KZ, Huang XY. Lin HW, et al. Inorg Chem. 2023 Nov 13;62(45):18331-18337. doi: 10.1021/acs.inorgchem.3c02960. Epub 2023 Nov 1. Inorg Chem. 2023. PMID: 37910803

5

The crosstalk between NLRP3 inflammasome and gut microbiome in atherosclerosis.

Zhang XN, Yu ZL, Chen JY, Li XY, Wang ZP, Wu M, Liu LT. Zhang XN, et al. Pharmacol Res. 2022 Jul;181:106289. doi: 10.1016/j.phrs.2022.106289. Epub 2022 Jun 6. Pharmacol Res. 2022. PMID: 35671922 Review.

6

Targets of statins intervention in LDL-C metabolism: Gut microbiota.

Sun C, Wang Z, Hu L, Zhang X, Chen J, Yu Z, Liu L, Wu M. Sun C, et al. Among authors: wang z. Front Cardiovasc Med. 2022 Sep 8;9:972603. doi: 10.3389/fcvm.2022.972603. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36158845 Free PMC article. Review.

7

SIRT3: A potential therapeutic target for liver fibrosis.

Ning Y, Dou X, Wang Z, Shi K, Wang Z, Ding C, Sang X, Zhong X, Shao M, Han X, Cao G. Ning Y, et al. Among authors: wang z. Pharmacol Ther. 2024 May;257:108639. doi: 10.1016/j.pharmthera.2024.108639. Epub 2024 Mar 30. Pharmacol Ther. 2024. PMID: 38561088 Review.

8

Synthesis and Evaluation of Fluorine-18-Labeled L-Rhamnose Derivatives.

Zhang X, Basuli F, Shi ZD, Shah S, Shi J, Mitchell A, Lai J, Wang Z, Hammoud DA, Swenson RE. Zhang X, et al. Among authors: wang z. Molecules. 2023 Apr 27;28(9):3773. doi: 10.3390/molecules28093773. Molecules. 2023. PMID: 37175182 Free PMC article.

9

Protective effects of paeoniflorin on cardiovascular diseases: A pharmacological and mechanistic overview.

Li X, Sun C, Zhang J, Hu L, Yu Z, Zhang X, Wang Z, Chen J, Wu M, Liu L. Li X, et al. Among authors: wang z. Front Pharmacol. 2023 May 30;14:1122969. doi: 10.3389/fphar.2023.1122969. eCollection 2023. Front Pharmacol. 2023. PMID: 37324475 Free PMC article. Review.

10

Diaryl Ether Formation by a Versatile Thioesterase Domain.

Wei Q, Wang ZP, Zhang X, Zou Y. Wei Q, et al. J Am Chem Soc. 2022 Jun 8;144(22):9554-9558. doi: 10.1021/jacs.2c02813. Epub 2022 May 31. J Am Chem Soc. 2022. PMID: 35639490

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

94 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Results by year